Real Patient Testimonials
Supplement recommendations for GLP-1 users apply equally to retatrutide, since the appetite suppression mechanisms are similar across the class
Common symptoms include dizziness, lightheadedness, blurred vision, fatigue, nausea, difficulty concentrating, and in severe cases, syncope (fainting)
Based on the current status of the Phase 3 TRIUMPH program, Eli Lilly is expected to file a New Drug Application (NDA) in late 2026
While Ozempic teeth isnt a formal diagnosis, the growing number of reports about dry mouth, enamel erosion, and even tooth loss point to a real concern for many patients
For patients with existing heart disease, semaglutide's proven CV benefit is a major differentiator